MarketsBeta

Platform in test version·information shown is for guidance only and does not constitute investment advice.

UMED

UNIMED

Continuous
8.270TND
+0.00%(+0.000)
Sector
Health Care
Market Cap
264.6M TND
ISIN
TN0007720014
Today's Session
Prev Close
8.270
Open
8.270
High
8.350
Low
8.230
Thresholds
7.780 - 8.760
Volume
116.4K TND
13,994 shares
Performance
YTD Change
-12.49%
20D Volatility
17.00%
Annualized
52W High
10.950
52W Low
7.990

Changes follow BVMT's convention: on a day without trades, the close is the reference price.

About UNIMED

View all

UNIMED is a Tunisian pharmaceutical manufacturer specializing in sterile products: injectables, eye drops, ophthalmic solutions, and infusion fluids. Founded in 1989 in Sousse and listed since 2016, the company produces generic drugs under its own brand and through contract manufacturing for third-party laboratories.

Listed
2016
Shares outstanding
32,000,000
Major shareholders · as of 17 Jun 2026
  • PREMIUM HOLDING
    40.8%
  • Ridha Ben Ali CHARFEDDINE
    29.3%

Key figures 2025

Consolidated
View all
Revenue
149.02m TND
Net income
18.6m TND
Earnings per share
0.581 TND
P/E at year end
16.26
Net margin
12.48%
ROE
15.96%
Dividend per share
0.625 TND

Technical indicators

View all
RSI (14)
33.4
vs 200-day average
-11.13%
vs 52-week high
-24.47%
12-month performance
+3.50%
Support
7.520
Resistance
9.650
1-month performance
-3.84%
3-month performance
-18.68%

Computed as of 18 Nov 2026. For information only, not investment advice.

UMED price · 3 months

View all
3-month change
-16.46%
3-month high
10.280
3-month low
8.150
18 Aug 202618 Nov 2026
Latest sessions
DateCloseChange %
18 Nov 20268.2700.00%
17 Nov 20268.270-0.36%
16 Nov 20268.3000.00%
13 Nov 20268.3000.00%
12 Nov 20268.300-1.19%

Prices adjusted for corporate actions. Source: BVMT.

Meetings and dividends

View all
Latest assembly FY 2025AGO
June 17, 2026
10HSiège de la Société UNIMED sis à la Zone Industrielle Kalâa Kébira
Latest dividend for FY 2025Dividend
September 9, 2026
0.625 DT/sharePayment Sep 9, 2026

Latest filings

View all

Latest news

View all